Akeso, Inc. (AKESF)
7.446
-0.40
(-5.15%)
USD |
OTCM |
Nov 18, 16:00
Akeso Enterprise Value : 6.812B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 6.812B |
| November 17, 2026 | 7.183B |
| November 16, 2026 | 7.468B |
| November 13, 2026 | 9.429B |
| November 12, 2026 | 9.760B |
| November 11, 2026 | 10.49B |
| November 10, 2026 | 10.49B |
| November 09, 2026 | 10.49B |
| November 06, 2026 | 9.792B |
| November 05, 2026 | 9.507B |
| November 04, 2026 | 9.608B |
| November 03, 2026 | 9.158B |
| November 02, 2026 | 9.388B |
| October 30, 2026 | 10.08B |
| October 29, 2026 | 10.08B |
| October 28, 2026 | 9.715B |
| October 27, 2026 | 9.618B |
| October 26, 2026 | 9.847B |
| October 23, 2026 | 9.939B |
| October 22, 2026 | 9.930B |
| October 21, 2026 | 11.12B |
| October 20, 2026 | 11.12B |
| October 19, 2026 | 10.52B |
| October 16, 2026 | 10.31B |
| October 15, 2026 | 10.31B |
| Date | Value |
|---|---|
| October 14, 2026 | 11.00B |
| October 13, 2026 | 12.05B |
| October 12, 2026 | 13.33B |
| October 09, 2026 | 13.33B |
| October 08, 2026 | 12.65B |
| October 07, 2026 | 12.65B |
| October 06, 2026 | 12.60B |
| October 05, 2026 | 12.60B |
| October 02, 2026 | 12.32B |
| October 01, 2026 | 12.43B |
| September 30, 2026 | 12.18B |
| September 29, 2026 | 11.91B |
| September 28, 2026 | 11.55B |
| September 25, 2026 | 11.55B |
| September 24, 2026 | 11.45B |
| September 23, 2026 | 10.86B |
| September 22, 2026 | 11.32B |
| September 21, 2026 | 11.57B |
| September 18, 2026 | 10.52B |
| September 17, 2026 | 10.47B |
| September 16, 2026 | 10.78B |
| September 15, 2026 | 11.24B |
| September 14, 2026 | 11.32B |
| September 11, 2026 | 10.81B |
| September 10, 2026 | 11.40B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ascletis Pharma, Inc. | 567.37M |
| CStone Pharmaceuticals Co. Ltd. | 966.82M |
| RemeGen Co., Ltd. | 4.804B |
| InnoCare Pharma Ltd. | 2.178B |
| Adagene, Inc. | 209.48M |
Enterprise Value Related Metrics
| Earnings Yield | -2.03% |
| Normalized Earnings Yield | -2.040 |